These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9879777)

  • 1. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells.
    El Etreby MF; Liang Y; Wrenn RW; Schoenlein PV
    Breast Cancer Res Treat; 1998 Sep; 51(2):149-68. PubMed ID: 9879777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture.
    El Etreby MF; Liang Y; Lewis RW
    Prostate; 2000 Apr; 43(1):31-42. PubMed ID: 10725863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
    Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
    Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells.
    Liang Y; Eid MA; El Etreby F; Lewis RW; Kumar MV
    Int J Oncol; 2002 Dec; 21(6):1259-67. PubMed ID: 12429976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
    Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
    Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer.
    Schoenlein PV; Hou M; Samaddar JS; Gaddy VT; Thangaraju M; Lewis J; Johnson M; Ganapathy V; Kallab A; Barrett JT
    Int J Oncol; 2007 Sep; 31(3):643-55. PubMed ID: 17671693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.
    Periyasamy-Thandavan S; Takhar S; Singer A; Dohn MR; Jackson WH; Welborn AE; LeRoith D; Marrero M; Thangaraju M; Huang S; Schoenlein PV
    Breast Cancer Res; 2012 Mar; 14(2):R52. PubMed ID: 22429491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells.
    Danforth DN
    J Endocrinol; 2004 Nov; 183(2):395-404. PubMed ID: 15531727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of danazol and mifepristone on the cytotoxicity of UCN-01 in hormone-responsive breast cancer cells.
    Yokoyama Y; Shinohara A; Takahashi Y; Wan X; Takahashi S; Niwa K; Tamaya T
    Anticancer Res; 2000; 20(5A):3131-5. PubMed ID: 11062733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells.
    Diel P; Smolnikar K; Michna H
    Breast Cancer Res Treat; 1999 Nov; 58(2):87-97. PubMed ID: 10674872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
    Adam L; Crépin M; Isräel L
    Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
    Thomas M; Monet JD
    J Clin Endocrinol Metab; 1992 Sep; 75(3):865-70. PubMed ID: 1517379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin.
    Otto AM; Paddenberg R; Schubert S; Mannherz HG
    J Cancer Res Clin Oncol; 1996; 122(10):603-12. PubMed ID: 8879258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogens are pro-apoptotic in normal human breast epithelial cells.
    Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A
    Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture.
    Swiatecka J; Dziecioł J; Anchim T; Dabrowska M; Pietruczuk M; Wołczyński S
    Neoplasma; 2000; 47(1):15-24. PubMed ID: 10870682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
    Perry RR; Kang Y; Greaves BR
    Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
    Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
    Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.
    Bardon S; Vignon F; Montcourrier P; Rochefort H
    Cancer Res; 1987 Mar; 47(5):1441-8. PubMed ID: 3815345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.